论文部分内容阅读
目的:观察健脾化瘀解毒法治疗晚期原发性肝癌的疗效。方法:将69例患者随机分为治疗组36例,对照组33例,2组均给予一般对症、护肝治疗;治疗组加用健脾化瘀解毒法中药治疗,1月为1疗程,2疗程后统计疗效。观察生活质量,中医症状改善情况,治疗前后瘤体变化及生存时间等。结果:治疗组生活质量Karnofsky评分改善方面优于对照组(P<0.05);治疗组胁痛、乏力、腹胀、纳呆等中医症状改善程度均优于对照组(P<0.05),治疗前后瘤体变化评定2组比较,差异无显著性意义(P>0.05);2组3个月生存率比较,差异无显著性意义(P>0.05),但6个月、1年生存率,治疗组分别为50.0%、36.1%;对照组分别为21.2%、12.1%,治疗组优于对照组,差异均有显著性意义(P<0.05)。结论:健脾化瘀解毒法治疗晚期原发性肝癌,可以提高患者生活质量,改善患者中医症状,延长生存期。
Objective: To observe the efficacy of Jianpi Huayu detoxification in the treatment of advanced primary liver cancer. Methods: Sixty-nine patients were randomly divided into treatment group (36 cases) and control group (33 cases). The two groups were given general symptomatic treatment and liver protection treatment. The treatment group was treated with traditional Chinese medicine of strengthening spleen and removing blood stasis, After treatment, statistical effect. Observe the quality of life, improve the symptoms of Chinese medicine, tumor changes before and after treatment and survival time. Results: The improvement of Karnofsky score in the treatment group was better than that in the control group (P <0.05). The symptoms of Chinese medicine such as hypochondriac pain, fatigue, abdominal distension and appetite in the treatment group were better than those in the control group (P <0.05) (P> 0.05). There was no significant difference in survival rate between the two groups at 3 months (P> 0.05), but there was no significant difference between the two groups in the 3-month survival rate Respectively, 50.0% and 36.1% respectively. The control group was 21.2% and 12.1% respectively. The treatment group was superior to the control group with significant difference (P <0.05). Conclusion: The therapy of invigorating the spleen and removing blood stasis and detoxification in the treatment of advanced primary liver cancer can improve the quality of life of patients, improve the symptoms of Chinese patients and prolong the survival period.